← Back to Clinical Trials
Recruiting NCT06949696

NCT06949696 Effect of Dual-Task Training and Cognitive Rehabilitation in Individuals With Multiple Sclerosis.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06949696
Status Recruiting
Phase
Sponsor Toros University
Condition Multiple Sclerosis
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-04-20
Primary Completion 2025-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Dual Task TrainingCognitive RehabilitationConventionel Physiotherapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-04-20 with a primary completion date of 2025-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to examine the effects of dual-task training and cognitive rehabilitation on gait, balance, fatigue and cognitive performance in individuals with multiple sclerosis.

Eligibility Criteria

Inclusion Criteria: * Definite MS diagnosis by a neurologist * Can walk independently * Expanded Disability Status Scale (EDSS) score below 5 * Has not had an attack in the last 3 months, has been medically stable for 6 months * Has not received a regular physiotherapy program in the last 6 months volunteer Exclusion Criteria: * Scoring 26 or below on the Montreal Cognitive Assessment Scale (MoCA) * Having systemic, orthopedic and neurological problems that may affect walking and balance in the assessments * Having additional psychiatric disorders

Contact & Investigator

Central Contact

Aysun Katmerlikaya, MSc

✉ aysun.katmerlikaya@toros.edu.tr
Principal Investigator

Aysun Katmerlikaya, MSc

PRINCIPAL INVESTIGATOR

Toros University

Frequently Asked Questions

Who can join the NCT06949696 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06949696 currently recruiting?

Yes, NCT06949696 is actively recruiting participants. Contact the research team at aysun.katmerlikaya@toros.edu.tr for enrollment information.

Where is the NCT06949696 trial being conducted?

This trial is being conducted at Mersin, Turkey (Türkiye).

Who is sponsoring the NCT06949696 clinical trial?

NCT06949696 is sponsored by Toros University. The principal investigator is Aysun Katmerlikaya, MSc at Toros University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology